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Nursing Care of Cardiac
Patients With Depression
Patient Health Questionnaire (PHQ-2)
Serious Mental Illlness and Heart Disease
“Patients with severe mental illnesses, such as schizophrenia, bipolar disorder and 
depression together affect 5%-10% of the U.S. population, lose 25 or more years 
of life expectancy, with the majority of the excess premature deaths due to CVD, 
not suicide.” (Newcomer and Hennekens)
Heart Disease and Mental Illness
 •  1 in 5 people will have an episode of major depression in their lifetime. That 
number climbs to about 1 in 2 for people with heart disease.
 •  The risk of heart disease is double for people with a history of depression.
 •  Major depression puts heart attack victims at greater risk and appears to add to 
the patient’s disability from heart disease. (World Federation of Mental Health)
 •  Hospitalized patients over 70 years-of-age who suffer from a combination of HF 
and depression experience readmission rates of 67% versus 44% among the 
same age group with HF but without depression. (Rozzini) 
 •  Patients with HF are twice as likely to die if they have depression compared with 
those who did not have depression. (Silver)
 •  A multicenter study demonstrated that even at three months following a 
hospitalization, 63% of HF patients reported symptoms of depression.
 •  Patients with stable CHD plus generalized anxiety disorder (GAD) have a higher 
risk of experiencing cardiovascular events such as stroke, myocardial infarction, 
and death than patients with CHD only.
 •  GAD was associated with a 74% increased risk for adverse cardiovascular 
outcomes. (E. Martins, World Federation for Mental Health)
Primary vs. Secondary Diagnosis
 •  It is unclear if it is an independent primary diagnosis or if the depressive 
symptoms are secondary to the patients’ chronic, complex illness.
 •  Both diagnoses share common pathophysiologic pathways and benefit from 
disease specific specialty care early in their diagnosis.
Depression and NYHA Functional Class
 •  A meta-analysis in 2006, performed by Rutledge, et. al., demonstrated a direct 
relationship between HF functional class and severity of depression.
 •  Patients with NYHA functional class I (mild) HF suffered an 11% occurrence of 
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Depression and NYHA Functional Class
Screening for endogenous or prolonged reactive depression in patients with HF 
is recommended by the 2012 HFSA guidelines following diagnosis. The AHA 
recommends screening and treatment for depressive symptoms in an  attempt to 
improve self-care behaviors and physical functioning.




Lehigh Valley Health Network is a 985 bed tertiary care hospital in Northeastern 
Pennsylvania with Heart Failure (HF) patient volumes 4 to 6 times the national average. 
In an effort to reduce 30 day all cause readmissions in this high risk population, a 
multidisciplinary team was convened. 
To prioritize continuum of care issues leading to measurable improvements consistent 
with the fundamental priorities of People, Service, Quality, Cost and Growth, Psychiatric 
nurse leadership was invited to provide expertise in the management of our complex HF 
patients with depression. Subsequently, a plan was developed to educate our cardiac 
nurses.
A LVHN Heart Failure Readmission Reduction Project Team works on improved 
outcomes and the reduction in inpatient readmissions for our patients with Congested 
Heart Failure.  In 2012, they invited a Psychiatric Nurse to join this group.  
We made a plan to educate our cardiac nurses on depression and screen all patients 
admitted to our Regional Heart Center who carried the diagnosis of CHF.  We screened 
for depression utilizing the PHQ2. This depression screen along with Suicide screening 
results were reported and discussed with the attending physician. In some cases 
immediate consults to Psychiatry were made to provide for patient safety and initiate 
treatment. Patients with positive scores, who were not in immediate need, were referred 
for follow up in outpatient settings.  
PHQ2 and PHQ9 screening of patients in LVHN practices can be completed and 
monitored through our Electronic Medical Record, Centricity Physician Office.  We 
have begun to standardize the monitoring process in multiple settings.  It is through 
these nursing collaborations that Cardiac Nurses and Psychiatric Nurses educate and 
coordinate improved care for our patients.  Integration occurs… two nurses at a time!
Depression Screening Results
Positive Scores vs. Consultations Ordered
42% Positive Screenings
Consults Ordered on 10%
of Positive Screenings
PHQ-9 Patient Depression Questionnaire
For initial diagnosis:
1. Patient completes PHQ-9 Quick Depression Assessment.
2. If there are at least 4 s in the shaded section (including Questions #1 and #2), consider a depressive
disorder. Add score to determine severity.
Consider Major Depressive Disorder
- if there are at least 5 s in the shaded section (one of which corresponds to Question # 1 or #2)
Consider Other Depressive Disorder
- if there are 2-4 s in the shaded section (one of which corresponds to Question #1 or #2)
Note: Since the questionnaire relies on patient self-report, all responses should be verified by the clinician,
and a definitive diagnosis is made on clinical grounds taking into account how well the patient understood the
questionnaire, as well as other relevant information from the patient.
Diagnoses of Major Depressive Disorder or Other Depressive Disorder also require impairment of social,
occupational, or other important areas of functioning (Question #10) and ruling out normal bereavement, a
history or a Manic Episode (Bipolar Disorder), and a physical disorder, medication, or other drug as the
biological cause of the depressive symptoms.
To monitor severity over time for newly diagnosed patients or patients in current treatment for
depression:
1. Patients may complete questionnaires at baseline and at regular intervals (eg, every 2 weeks) at
home and bring them in at their next appointment for scoring or they may complete the questionnaire
during each scheduled appointment.
2. Add ups by column. For every : Several days = 1 More than half the days = 2 Nearly every day = 3
3. Add together column scores to get a TOTAL score.
4. Refer to the accompanying PHQ-9 Scoring Box to interpret the TOTAL score.
5. Results may be included in patient files to assist you in setting up a treatment goal, determining degree of
response, as well as guiding treatment intervention.
Scoring: add up all checked boxes on PHQ-9
For every ? Not at all = 0; Several days = 1;
More than half the days = 2; Nearly every day = 3
Interpretation of Total Score




15-19 Moderately severe depression
20-27 Severe depression
PHQ9 Copyright © Pfizer Inc. all rights reserved. Reproduced with permission. PRIME-MD ® is a
trademark of Pfizer Inc.
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The Patient Health Questionnaire-2 (PHQ-2) - Overview
The PHQ-2 inquires about the frequency of depressed mood and anhedonia over the past two
weeks. The PHQ-2 includes the first two items of the PHQ-9.
 The purpose of the PHQ-2 is not to establish final a diagnosis or to monitor depression
severity, but rather to screen for depression in a “first step” approach.
 Patients who screen positive should be further evaluated with the PHQ-9 to determine
whether they meet criteria for a depressive disorder.
Clinical Utility
Reducing depression evaluation to two screening questions enhances routine inquiry about the
most prevalent and treatable mental disorder in primary care.
Scoring
A PHQ-2 score ranges from 0-6. The authors¹ identified a PHQ-2 cutoff score of 3 as the optimal
cut point for screening purposes and stated that a cut point of 2 would enhance sensitivity,
whereas a cut point of 4 would improve specificity.
Psychometric Properties¹











1 97.6 59.2 15.4 1 90.6 65.4 36.9
2 92.7 73.7 21.1 2 82.1 80.4 48.3
3 82.9 90.0 38.4 3 62.3 95.4 75.0
4 73.2 93.3 45.5 4 50.9 97.9 81.2
5 53.7 96.8 56.5 5 31.1 98.7 84.6
6 26.8 99.4 78.6 6 12.3 99.8 92.9
* Because the PPV varies with the prevalence of depression, the PPV will be higher in settings with a higher prevalence
of depression and lower in settings with a lower prevalence.
1. Kroenke K, Spitzer RL, William JB. The Patient Health Questionnaire-2: Validity of a Two-Item Depression
Screener. Medical Care 2003, (41) 1284-1294.
The Patient Health Questionnaire-2 (PHQ-2)
Patient Name Date of Visit
Over the past 2 weeks, how often have you












1. Little interest or pleasure in doing things 0 1 2 3
2. Feeling down, depressed or hopeless 0 1 2 3
©1999 Pfizer Inc. All rights reserved. Used with permission.
PATIENT HEALTH QUESTIONNAIRE (PHQ-9)
NAME: DATE:
Over the last 2 weeks, how often have you been
bothered by any of the following problems?
(use “? ” to indicate your answer)





1. Little interest or pleasure in doing things
0 1 2 3
2. Feeling down, depressed, or hopeless 0 1 2 3
3. Trouble falling or staying asleep, or sleeping too much 0 1 2 3
4. Feeling tired or having little energy 0 1 2 3
5. Poor appetite or overeating 0 1 2 3
6. Feeling bad about yourself - or that you are a failure or have let yourself
or your family down
0 1 2 3
7.Trouble concentrating on things, such as reading the newspaper or
watching television
0 1 2 3
8. Moving or speaking so slowly that other people could have noticed. Or
the opposite – being so fidgety or restless that you have been moving
around a lot more than usual
0 1 2 3
9.Thoughts that you would be better off dead, or of hurting yourself 0 1 2 3
add columns + +
(Healthcare professional: For interpretation of TOTAL,
please refer to accompanying scoring card).
TOTAL
10. If you checked off any problems, how difficult
have these problems made it for you to do
your work, take care of things at home, or get
along with other people?
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